Cellectis (CLLS) Current Assets (2014 - 2026)

Cellectis (CLLS) recorded quarterly Current Assets of $204.5 million in Q1 2026, down 13.42% quarter-over-quarter from $236.2 million in Q4 2025, and down 24.75% on a YoY basis from $271.8 million in Q1 2025.

Cellectis (CLLS) Current Assets (2014 - 2026) Analysis & Trends

Cellectis' Current Assets history runs 13 years deep, the most recent figure standing at $204.5 million for Q1 2026.

  • In Q1 2026, Current Assets fell 24.75% year-over-year to $204.5 million; the TTM figure through Mar 2026 stood at $204.5 million (down 24.75% YoY), while the FY2025 annual figure was $236.2 million, down 17.7% from the prior year.
  • Current Assets was $204.5 million for Q1 2026 at Cellectis, down from $236.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $305.8 million in Q2 2024 to a low of $96.5 million in Q3 2023.
  • Historically, Current Assets has averaged $206.0 million across 5 years, with a median of $221.2 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Current Assets plunged 45.86% in 2022, then jumped 205.13% in 2024.
  • A 5-year view of Current Assets shows it stood at $122.0 million in 2022, then jumped by 90.92% to $233.0 million in 2023, then advanced by 23.2% to $287.1 million in 2024, then slipped by 17.7% to $236.2 million in 2025, then fell by 13.42% to $204.5 million in 2026.
  • The last three Current Assets figures came in at $204.5 million (Q1 2026), $236.2 million (Q4 2025), and $221.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.31 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 521.86 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 10.37 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.25 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 3.59 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 11.73 Bn
9 Abivax 91.96 Bn 91.96 Bn - 600.85 Mn
10 Cellectis 17.40 Bn 17.21 Bn - 204.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 204.55 Mn
Dec 31, 2025 236.24 Mn
Sep 30, 2025 221.19 Mn
Jun 30, 2025 230.64 Mn
Mar 31, 2025 271.83 Mn
Dec 31, 2024 287.07 Mn
Sep 30, 2024 294.43 Mn
Jun 30, 2024 305.80 Mn
Mar 31, 2024 258.07 Mn
Dec 31, 2023 233.01 Mn
Sep 30, 2023 96.49 Mn
Jun 30, 2023 113.29 Mn
Mar 31, 2023 117.23 Mn
Dec 31, 2022 122.04 Mn
Sep 30, 2022 140.27 Mn
Jun 30, 2022 175.17 Mn
Mar 31, 2022 195.18 Mn
Dec 31, 2021 225.43 Mn
Sep 30, 2021 235.85 Mn
Jun 30, 2021 280.35 Mn